Patients | pharmaphorum

News

Patients rely on Google more than information leaflets

It is time to look at new, digital ways to deliver patient information, suggests UK survey.

News

PTC’s gene therapy for rare disease cleared for NHS use

Upstaza has shown impressive clinical results in children with fatal disorder AADC deficiency.

Patients

Challenges and opportunities with plasma-derived therapies

This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.

News

FDA advisors split on Biogen’s ALS therapy

But unanimous vote on biomarker validity could support accelerated approval of tofersen.

News

Novartis pulls plug on landmark UK cholesterol trial

ORION-17 study has been abandoned, with Novartis opting instead for a smaller global trial.

News

FDA advisors split on Biogen’s ALS therapy

But unanimous vote on biomarker validity could support accelerated approval of tofersen.

News

Novartis pulls plug on landmark UK cholesterol trial

ORION-17 study has been abandoned, with Novartis opting instead for a smaller global trial.

News

Rapid UTI tests could cut antibiotic resistance, says NICE

Rapid urine tests could help NHS ensure that antibiotics are used appropriately.

News

Patients rely on Google more than information leaflets

It is time to look at new, digital ways to deliver patient information, suggests UK survey.

News

PTC’s gene therapy for rare disease cleared for NHS use

Upstaza has shown impressive clinical results in children with fatal disorder AADC deficiency.

Press Releases

Digital

Partner Content

Newel Health awarded $2.5M Michael J. Fox research grant

Newel Health has been awarded a $2.5 million research grant from The Michael J. Fox Foundation.

Partner Content

The RARE Youth Revolution has begun

RARE Revolution Magazine proudly launches dedicated RARE youth online platform

Views & Analysis

Patients

Challenges and opportunities with plasma-derived therapies

This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.

Patients

Tech to make healthcare more accessible for Latinx patients

How emerging technology could make healthcare more accessible for Spanish-speaking communities.

Deep Dive

Patients

Company profile ZS Associates

ZS Associates is transforming global healthcare by driving toward a connected ecosystem.

Patients

Talent across borders: opening doors for refugee pharmacists...

The idea of rebuilding your life from scratch, far away from the people, culture, and places you know and love, would be challenging for many people.

Patients

Inside the pharmaceutical greenhouse

For centuries, millions of people around the world have turned to the plants and trees around them to develop herbal and traditional remedies.

Patients

Sponsored

Measuring the intangible – what is the true value of a “pati...

Debates & Insight

Sponsored

Digital health: how can technology be used to engage hard-to...

Helping someone live with a condition as complex as MS can be fraught with challenges.

Debates & Insight

Sponsored

The future of the clinical trial: collaboration and patient ...

Podcasts

Patients

Challenges and opportunities with plasma-derived therapies

This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.

Patients

CinCor Pharma: A small pharma’s journey to acquisition

In this week's podcast, pharmaphorum welcomes Marc de Garidel, CEO of CinCor Pharma.

Digital

Sponsored

AI trends in 2023

AI in pharma is trending toward a moment of maturity, reliability, and scalability.

Video

Digital

Health Innovators – Abby Staible and Dan Vahdat

AstraZeneca has been working with Huma to explore ways to improve patient experience.

R&D

JP Morgan 2023 – Joe Spinelli

Editor-in-chief Jonah Comstock chats virtually with Aranscia's Joe Spinelli.

R&D

JP Morgan 2023 – Lisa Yañez

At JP Morgan Week, pharmaphorum caught up with Lisa Yañez, CEO of Aerami Therapeutics.

White Papers

Debates & Insight

Sponsored

Patient centricity: How does Boehringer Ingelheim UK measure...

Patient centricity is a subject that is massively talked about but few can 'walk the talk'.

Debates & Insight

Sponsored

Patient centricity: What it means and why it’s important to ...

Having clear parameters of patient‑centricity that can be measured year-on-year enables Boehringer Ingelheim UK to know if it is moving in the right direction and to set targets for what it hop

Debates & Insight

Sponsored

Improved health and wellbeing in COPD

Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating disorder, which, as it progresses, places a significant burden on individuals and those caring for them.

Patients

Sponsored

Measuring the intangible – what is the true value of a “pati...

Views & Analysis

Words, inclusivity, and the struggle for health equality

Outdated or offensive terminology can reinforce barriers to clinical trial participation and accessible healthcare.

Views & Analysis

Sponsored

Understanding blockchain – a practical guide for life scienc...

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in distributed ledger technology (DLT) on the rise, then it would appear that momentum is b

Partner Content

Illuminating Real-Time Patient Needs Through Socially Driven...

Data collected via social health adds context, recency

Partner Content

Influencer Marketing and Social Health: Optimizing Pharma's ...

How to execute meaningful, scalable campaigns

Partner Content

Understanding the True Impact of the COVID-19 Pandemic on th...

Complexities demonstrate the need for more resources

Patients rely on Google more than information leaflets

PTC’s gene therapy for rare disease cleared for NHS use

Challenges and opportunities with plasma-derived therapies

FDA advisors split on Biogen’s ALS therapy

Novartis pulls plug on landmark UK cholesterol trial

FDA advisors split on Biogen’s ALS therapy

Novartis pulls plug on landmark UK cholesterol trial

Rapid UTI tests could cut antibiotic resistance, says NICE

Patients rely on Google more than information leaflets

PTC’s gene therapy for rare disease cleared for NHS use

Newel Health awarded $2.5M Michael J. Fox research grant

The RARE Youth Revolution has begun

Challenges and opportunities with plasma-derived therapies

Tech to make healthcare more accessible for Latinx patients

Company profile ZS Associates

Talent across borders: opening doors for refugee pharmacists...

Inside the pharmaceutical greenhouse

Measuring the intangible – what is the true value of a “pati...

Digital health: how can technology be used to engage hard-to...

The future of the clinical trial: collaboration and patient ...

Challenges and opportunities with plasma-derived therapies

CinCor Pharma: A small pharma’s journey to acquisition

AI trends in 2023

Health Innovators – Abby Staible and Dan Vahdat

JP Morgan 2023 – Joe Spinelli

JP Morgan 2023 – Lisa Yañez

Patient centricity: How does Boehringer Ingelheim UK measure...

Patient centricity: What it means and why it’s important to ...

Improved health and wellbeing in COPD

Measuring the intangible – what is the true value of a “pati...

Words, inclusivity, and the struggle for health equality

Understanding blockchain – a practical guide for life scienc...

Illuminating Real-Time Patient Needs Through Socially Driven...

Influencer Marketing and Social Health: Optimizing Pharma's ...

Understanding the True Impact of the COVID-19 Pandemic on th...

Former Seagen CEO Siegall pops up at new biotech

An inside guide to unlocking clinical research in the UK

Others Old
-About pharmaphorum
-Articles
--eyeforpharma Barcelona 2015
-Audio
-barelonalive 2016
-Cancer
-Diabetes
--Diabetes
-Disease Spotlight
--DMD Main
--LHON Main
-ESMO2016
-ESMO2016-related
-Event coverage
--ASCO-slider
--ASCO-pp
--ASCO-contributor
--ASCO 2018
-Featured content right column
-Featured Event
-Jobs
--pharmaphorum-live
-Medical Affairs Spotlight
--Medical Affairs Spotlight - partner
--Medical Affairs Spotlight - main
-Podcast
-Premium media
-Quintiles
--Quintiles-oncol-PC
--Quintiles - ContentIO
--Quintiles - Articles
--Quintiles - Oncol articles
-Roundtables
--AZ-roundtable-biographies-2017
--AZ-roundtable-interviews-2017
--AZ-roundtable-debate-2017
-Sales and Marketing
--News
--Insights
--Appointments
--Debates
--Debates & Insight
--Views & Analysis
--Partner Content
-Slider in events
-Slider in home page
-Slider in video
-Slider in views and analysis
-Slider in webinars
-Slider in whitepapers
-Spotlight
--Understanding HCPs
--Future of Generics
--Frontiers Health 2022
--Frontiers Health 2021
--Behavioural Science
--ASCO 2019 Live coverage
--AI in Pharma Marketing
--ASCO 2019 and the future of oncology
-Startups
--Views & Analysis
--News
-System
-Top pharmaceutical companies
--Bristol-Myers Squibb
--Teva
--Roche
--Pfizer
--Novo Nordisk
--Novartis
--Merck Inc
--GlaxoSmithKline
--Gilead
--AstraZeneca
--AbbVie
-Top pharmaceutical companies
--Merck Inc
-Top stories
-Transversal Categories
--Brexit
--Clinical
--Digital and Social Media
--US
---Articles
--UK & Europe
--Sales and Marketing
--Rare diseases
--R&D
--Pharma Market Access
--M&A
--Healthcare
-Veeva
-Veeva channel content articles
-Veeva channel content webinars
-Video
-Views and analysis
-Webinars in home page
-Whitepapers
Others
-Transversal Categories
--Clinical
--Sustainability
--Brexit
--Digital and Social Media
--Healthcare
--US
--UK & Europe
--Sales & Marketing
--Rare diseases
--R&D
--Pharma Market Access
--M&A
-Top stories
-About pharmaphorum
-Top pharmaceutical companies
--Gilead
--Merck Inc
--Teva
--Roche
--Pfizer
--Novo Nordisk
--Novartis
--GlaxoSmithKline
--Bristol-Myers Squibb
--AstraZeneca
--AbbVie
-test webinar
-System
-Startups
--News
--Views & Analysis
-Veeva channel content webinars
-Webinars in home page
--Live webinar
--Webinars On demand
-Veeva channel content articles
-Veeva
-Spotlight
-Event coverage
--ASCO-slider
--ASCO-pp
--ASCO-contributor
--ASCO 2018
-ESMO2016-related
-ESMO2016
-Featured Event
-Disease Spotlight
--LHON Main
--DMD Main
-Diabetes
--Diabetes
-Cancer
-barelonalive 2016
-Audio
-Articles
--eyeforpharma Barcelona 2015
-Slider in whitepapers
-Featured content right column
-Jobs
--pharmaphorum-live
-Roundtables
--AZ-roundtable-interviews-2017
--AZ-roundtable-biographies-2017
--AZ-roundtable-debate-2017
-Slider in webinars
-Slider in views and analysis
-Slider in video
-Slider in home page
-Slider in events
-Quintiles
--Quintiles-oncol-PC
--Quintiles - Oncol articles
--Quintiles - ContentIO
--Quintiles - Articles
-Premium media
-Medical Affairs Spotlight
--Medical Affairs Spotlight - partner
--Medical Affairs Spotlight - main
Home
-News
-Views & Analysis
-Deep Dive
-Webinars
--Live webinar
-Podcasts
-Videos
-White Papers
-Events
--JP Morgan
--LSX Investech
--Anthropy
--Reuters Pharma 2022
--World Cancer Series
--Hlth 2022
--PM Society Awards
--Patient Summit PC
--Frontiers Health 2022
--FHlive17
--ASCO 2018
-Digital Debates
-Podcasts & Videos
-Partner Content
--Events
--News
--Appointments
--Press releases
Digital
-Appointments
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Market Access
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Oncology
-Appointments
-Debates
-Insights
-News
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Patients
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
R&D
-Appointments
-Debates
-Debates & Insights
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Partner Content
-Debates & Insight
Sales & Marketing
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Spotlight on
-AI in Pharma Marketing
-ASCO 2019 and the future of oncology
-ASCO 2019 Live coverage
-Behavioural Science
-Frontiers Health 2021
-Frontiers Health 2022
-Future of Generics
-Understanding HCPs
-The Future of Generics

News

Press Releases

Views & Analysis

Editor's Picks

Deep Dive

Webinars

Podcasts

Video

White Papers

Debates & Insight

Partner Content

Editor's Picks